CoChat

Unilateral cancer-associated retinopathy: diagnosis, serology and treatment

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Purpose To report a case of unilateral cancer-associated retinopathy (CAR) with clinical, serological and electroretinogram (ERG) normalization after aggressive cancer treatment combined with steroids and rituximab.Methods Work-up included extensive clinical and electrophysiological testing. Also, serological work-up for antiretinal antibodies and oncological screening was organized.Results A 45-year-old female presented with progressive photopsias, photophobia and relative central scotoma in the right eye since 6 weeks prior. BCVA was 1.0 in both eyes. Biomicroscopy, IOP and fundus exam were unremarkable. Also, colour vision, autofluorescence imaging, OCT and EOG were normal. Visual fields showed decreased central sensitivity in the right eye. ERG showed a unilateral, electronegative combined and ON-bipolar response. A diagnosis of CAR was suspected. After a diagnosis of an adenocarcinoma of the right ovary, radical ovariectomy and hysterectomy were performed, followed by adjuvant chemotherapy. A whole-body PET scan revealed no metastasis. Treatment with rituximab monoclonal antibodies in combination with corticosteroids was initiated. The patient tested positive for serum autoantibodies against TRPM1, a transient receptor potential cation channel expressed in ON-bipolar cells. During treatment, there was progressive improvement in symptoms and the ERG normalized. Serology confirmed complete clearance of autoantibodies.Conclusions Although rare, unilateral CAR does occur and in cases with high clinical suspicion an oncological work-up is mandatory. Aggressive cancer treatment combined with steroids and rituximab can lead to normalization of the clinical and ERG phenotype, with clearing of antiretinal antibodies.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10633-017-9605-y

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Cited by

See all 35

Metadata

Authors
Roels, D., Ueno, S., Talianu, C. D., Draganova, D., Kondo, M., & Leroy, B. P.
Affiliations
  • Ghent University Hospital (BE)
  • Nagoya University (JP)
  • Hôpital Civil de Charleroi (BE)
  • Centre Hospitalier Universitaire Brugmann (BE)
  • Mie University (JP)
  • Children's Hospital of Philadelphia (US)
Corresponding author
Leroy, Bart P.
Venue
Documenta Ophthalmologica
Published
2017-08-16
Volume
135
Issue
3
Pages
233-240
ISSN
  • 0012-4486 (ISSN-L)
  • 1573-2622
OpenAlex
W2746996563
Cited by
35
References
19
Citations by year
2026: 3 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 5 · 2018: 2
FWCI
2.67
Type
journal article
Language
en
Open access
closed
Locations
  • Documenta Ophthalmologica (publishedVersion)
  • PubMed (publishedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Funders
Fonds Wetenschappelijk Onderzoek
Topics
  • Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
Keywords
cancer-associated retinopathy, rituximab, corticosteroids, ovarian adenocarcinoma, electroretinogram abnormalities, ON bipolar cells, adjuvant chemotherapy, photopsia, central scotoma
MeSH terms
Rituximab, Antineoplastic Agents, Immunological, Adenocarcinoma, Female, Humans, Middle Aged, Ovarian Neoplasms, Retinal Diseases, Steroids, Treatment Outcome, Paraneoplastic Syndromes, Ocular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unilateral cancer-associated retinopathy: diagnosis, serology and treatment. https://app.cochat.ai/papers/10.1007/s10633-017-9605-y
The paper
Roels, D., Ueno, S., Talianu, C. D., Draganova, D., Kondo, M., & Leroy, B. P. (2017). Unilateral cancer-associated retinopathy: diagnosis, serology and treatment. Documenta Ophthalmologica. https://doi.org/10.1007/s10633-017-9605-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.